Skip to main content

and
  1. No Access

    Article

    Effects of Sacubitril/Valsartan in Patients with High Arrhythmic Risk and an ICD: A Longitudinal Study

    Patients affected by heart failure with reduced ejection fraction (HFrEF) receive clinical and functional beneficial effects from treatment with sacubitril/valsartan. However previous studies have shown that p...

    Matteo Casale, Michele Correale, Giulia Laterra in Clinical Drug Investigation (2021)

  2. No Access

    Article

    Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Ezetimibe reduces plasma low-density lipoprotein cholesterol (LDL-C) levels by up to 20%. However, its effect on plasma lipoprotein(a) [Lp(a)] concentrations in patients with primary hypercholesterolemia has n...

    Kamal Awad, Dimitri P. Mikhailidis, Niki Katsiki, Paul Muntner, Maciej Banach in Drugs (2018)